Marjan Farid, M.D.
Board Member
KALA BIO, Inc. (KALA)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Marjan Farid, M.D.
Marjan Farid, M.D. is recorded as Board Member at KALA BIO, Inc. (KALA). KALA BIO, Inc. reported in an 8-K filed December 29, 2025 that Marjan Farid, M.D. resigned as director. KALA BIO, Inc. reported in an 8-K filed November 1, 2022 that Marjan Farid, M.D. was appointed member of the Board, effective October 31, 2022.
“each of Marjan Farid, M.D., Andrew I. Koven, C. Daniel Myers, Todd Bazmore, Mark Iwicki, and Howard B. Rosen tendered on December 19, 2025 a conditional resignation from their positions as director effective immediately after the Company's 2025 Annual Meeting if stockholder approval is obtained at such 2025 Annual Meeting”
“On October 31,, 2022, upon the recommendation of the Nominating and Corporate Governance Committee of Kala Pharmaceuticals, Inc. (the "Company"), the Board of Directors of the Company (the "Board") appointed Marjan Farid, M.D. as a member of the Board, effective immediately.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2022-10-31–present
-
2022-10-31–2025-12-29
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at KALA BIO, Inc.
Other people whose current roles at this company are on record from its filings.
- Avi Minkowitz CEO, CFO, Board Member
- Todd Bazemore CEO, COO
- the Purchaser CEO, Chairman
- David Lazar Chairman, Board Member
- Eric L. Trachtenberg General Counsel
- Brendan Purdy Board Member
- Chaim (Dovi) Berger Board Member
- Hillel Posen Board Member
- Rajeev Shah Board Member
- Yonatan Colman Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.